HF
LJPC

HRT Financial’s La Jolla Pharmaceutical Company LJPC Stock Holding History

HRT Financial’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-45,461
Closed -$181K – 4567
2021
Q3 		$181K Sell
45,461
-4,915
-10% -$19.5K ﹤0.01% 2729
2021
Q2 		$215K Buy
+50,376
New +$216K ﹤0.01% 2351

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HRT Financial's LJPC Position: Q4 2021 in Review

HRT Financial sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 45,461 shares — an estimated $181K sold.

HRT Financial first reported a position in LJPC in Q2 2021 and held it in 2 quarters. The position peaked at $215K in Q2 2021. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • HRT Financial reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • HRT Financial sold 45,461 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $181K.
  • HRT Financial first reported a position in La Jolla Pharmaceutical Company in Q2 2021 and held it in 2 quarters.
  • HRT Financial's La Jolla Pharmaceutical Company position peaked at $215K in Q2 2021.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.